Which contrast‑enhanced CT urography protocol should be ordered to evaluate microscopic hematuria?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

CT Urography for Microscopic Hematuria Workup

Order CT urography (CTU) with unenhanced images followed by IV contrast-enhanced nephrographic and excretory phases for patients with microscopic hematuria who have risk factors for malignancy. 1

Patient Selection for Imaging

Not all patients with microscopic hematuria require imaging. Do not order imaging for patients without risk factors who have an identified benign cause (vigorous exercise, infection, trauma, menstruation, or recent urologic procedure). 1

Risk Factors Requiring Full Workup:

  • Male gender
  • Age >35 years
  • Smoking history
  • Occupational chemical exposure
  • History of pelvic irradiation
  • Chronic urinary tract infection
  • Prior urologic disease
  • Irritative voiding symptoms
  • Analgesic abuse
  • Exposure to chemotherapy or carcinogenic agents
  • Chronic indwelling foreign body 1

Important caveat: Anticoagulant therapy does NOT eliminate the need for evaluation—these patients still require full workup. 1

The Optimal CT Protocol

CTU is the imaging study of choice because it evaluates both nephrogenic (kidney parenchymal) and urogenic (collecting system) causes of hematuria. 1

Standard CTU Protocol Components:

  • Unenhanced (non-contrast) phase - essential for detecting calculi and baseline assessment 1
  • Nephrographic phase - obtained after IV contrast administration 1
  • Excretory phase - acquired at least 5 minutes after contrast injection to visualize the collecting system 1
  • Thin-slice acquisition with multiplanar reconstructions (maximum intensity projection or 3-D volume rendering) 1

Alternative technique: Split-bolus protocol uses an initial contrast loading dose followed by a second dose to obtain a combined nephrographic-excretory phase. 1

Why CTU Outperforms Other Modalities

CTU demonstrates superior diagnostic accuracy with pooled sensitivity of 96% and specificity of 99% for detecting urothelial malignancy. 1

Comparative Performance:

  • Upper tract lesions (kidneys/ureters): CTU accuracy 99.6% vs. IVU 84.9% 1
  • Lower tract lesions (bladder): CTU specificity 98.8% and accuracy 97.2% 1
  • Better than MR urography: CTU provides superior visibility of urothelial structures and improved diagnostic confidence 1

What NOT to Order

Do not order standard "CT abdomen and pelvis with contrast" - this is NOT the same as CTU and lacks the critical unenhanced and excretory phases needed to properly evaluate the urinary tract. 1

Avoid these inadequate alternatives:

  • Ultrasound alone - lower sensitivity than CTU for urinary tract abnormalities 1
  • Intravenous urography (IVU) - obsolete with low sensitivity for renal masses 1
  • Plain radiographs (KUB) - not appropriate for hematuria evaluation 1
  • MR urography - decreased spatial resolution, misses small calculi and small urothelial lesions 1

Special Consideration: Young Patients

For patients <50 years old with microscopic hematuria and no risk factors, unenhanced CT alone may be sufficient. 2, 3, 4 In this population, the risk of upper urinary tract malignancy is <1.1%, and 91-95% of clinically significant findings are visible on unenhanced images alone. 2, 3, 4

This approach reduces radiation exposure and eliminates contrast-related risks in younger patients. 2, 3 However, if the patient has risk factors or predisposing medical conditions, proceed with full CTU protocol. 3

Pregnancy Exception

Do not use CTU in pregnant patients due to fetal radiation exposure. 1 The malignancy rate in pregnant women with microscopic hematuria is extremely low. 1 If imaging is absolutely necessary, ultrasound of kidneys and bladder is the appropriate choice. 1

Clinical Context

The malignancy risk with microscopic hematuria is only 2.6-4%, and most cases never identify a cause. 1 However, the primary goal of imaging is to exclude malignancy, which can occur anywhere in the urinary tract. 1 CTU's comprehensive evaluation of the entire urinary system makes it the definitive test when imaging is indicated. 1

Related Questions

In an adult man with gross hematuria and a recent urinary‑tract infection, who had a normal renal ultrasound two months ago, should a contrast‑enhanced CT urography still be performed to investigate the hematuria?
Is CT (Computed Tomography) urography the same as KUB (Kidneys, Ureters, Bladder) for a patient with hematuria and a history of cholecystectomy?
When is a CT (Computed Tomography) program with or without contrast indicated for patients presenting with hematuria (blood in urine)?
What alternative imaging modalities can be used to evaluate microscopic hematuria in patients with impaired renal function (elevated creatinine) who cannot undergo a CT urogram?
What is the appropriate management for a 38-year-old man with microscopic hematuria and a history of nephrolithiasis (kidney stones)?
In a 60-year-old woman with a history of pancreatitis who cannot use glucagon-like peptide-1 (GLP-1) receptor agonists, what are the best weight-loss medications available in Canada?
Is it normal for a 9‑month‑old infant to have no erupted primary teeth, and what follow‑up evaluation is recommended?
What is the recommended treatment for post‑nasal drip?
Which laboratory tests should be ordered for a 65-year-old female presenting with increased hair loss?
In patients with chronic post‑traumatic stress disorder (PTSD), is major depressive disorder (MDD) commonly present?
What is the appropriate next step in evaluating a persistent reactive cervical lymph node that has been present for several months?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.